U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Generalized clonic seizure

MedGen UID:
869081
Concept ID:
C4023499
Disease or Syndrome
Synonyms: Generalised clonic seizure; Generalised clonic seizures; Generalised onset clonic seizure; Generalised-onset clonic seizure; Generalized clonic seizures; Generalized onset clonic epileptic seizure; Generalized onset clonic seizure; Generalized-onset clonic epileptic seizure; Generalized-onset clonic seizure
SNOMED CT: Generalized clonic seizure (1208970009); Generalized onset clonic epileptic seizure (1208970009); Generalized-onset clonic epileptic seizure (1208970009)
 
HPO: HP:0011169

Definition

Generalized clonic seizure is a type of generalized motor seizure characterized by sustained bilateral jerking, either symmetric or asymmetric, that is regularly repetitive and involves the same muscle groups. [from HPO]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVGeneralized clonic seizure

Conditions with this feature

Severe myoclonic epilepsy in infancy
MedGen UID:
148243
Concept ID:
C0751122
Disease or Syndrome
SCN1A seizure disorders encompass a spectrum that ranges from simple febrile seizures and generalized epilepsy with febrile seizures plus (GEFS+) at the mild end to Dravet syndrome and intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC) at the severe end. Phenotypes with intractable seizures including Dravet syndrome are often associated with cognitive decline. Less commonly observed phenotypes include myoclonic astatic epilepsy (MAE), Lennox-Gastaut syndrome, infantile spasms, epilepsy with focal seizures, and vaccine-related encephalopathy and seizures. The phenotype of SCN1A seizure disorders can vary even within the same family.
Combined PSAP deficiency
MedGen UID:
382151
Concept ID:
C2673635
Disease or Syndrome
Combined saposin deficiency (PSAPD), a deficiency of prosaposin and saposins A, B, C, and D, is a fatal infantile storage disorder with hepatosplenomegaly and severe neurologic disease (summary by Hulkova et al., 2001).
Combined malonic and methylmalonic acidemia
MedGen UID:
481944
Concept ID:
C3280314
Disease or Syndrome
Combined malonic and methylmalonic aciduria (CMAMMA) is a rare recessive inborn error of metabolism characterized by elevations of urine malonic acid (MA) and methylmalonic acid (MMA). MMA excretion is higher than MA in CMAMMA patients, unlike patients with malonyl-CoA decarboxylase deficiency (248360) in whom the biochemical abnormalities include elevated MA alone or combined elevations of MA and MMA with MA mainly being higher than MMA. The clinical significance of CMAMMA is controversial. Initially, CMAMMA patients were ascertained during investigation of children with symptoms suggestive of a metabolic disorder or adults with neurologic manifestations (Sloan et al., 2011). Levtova et al. (2019) described CMAMMA patients identified by neonatal screening who had a favorable clinical course.
Developmental and epileptic encephalopathy, 13
MedGen UID:
482821
Concept ID:
C3281191
Disease or Syndrome
SCN8A-related epilepsy with encephalopathy is characterized by developmental delay, seizure onset in the first 18 months of life (mean 4 months), and intractable epilepsy characterized by multiple seizure types (generalized tonic-clonic seizures, infantile spasms, and absence and focal seizures). Epilepsy syndromes can include Lennox-Gastaut syndrome, West syndrome, and epileptic encephalopathies (e.g., Dravet syndrome). Hypotonia and movement disorders including dystonia, ataxia, and choreoathetosis are common. Psychomotor development varies from normal prior to seizure onset (with subsequent slowing or regression after seizure onset) to abnormal from birth. Intellectual disability, present in all, ranges from mild to severe (in ~50% of affected individuals). Autistic features are noted in some. Sudden unexpected death in epilepsy (SUDEP) of unknown cause has been reported in approximately 10% of published cases. To date SCN8A-related epilepsy with encephalopathy has been reported in the literature in about 50 individuals.
Developmental and epileptic encephalopathy, 28
MedGen UID:
863956
Concept ID:
C4015519
Disease or Syndrome
Developmental and epileptic encephalopathy-28 (DEE28) is an autosomal recessive severe neurologic disorder characterized by the onset of refractory seizures in the first months of life. Affected individuals have severe axial hypotonia and profoundly impaired psychomotor development. More severely affected patients have acquired microcephaly, poor or absent visual contact, and retinal degeneration; early death may occur (summary by Mignot et al., 2015). For a general phenotypic description and a discussion of genetic heterogeneity of DEE, see 308350.
Kohlschutter-Tonz syndrome-like
MedGen UID:
1781649
Concept ID:
C5543202
Disease or Syndrome
Den Hoed-de Boer-Voisin syndrome (DHDBV) is characterized by global developmental delay with moderately to severely impaired intellectual development, poor or absent speech, and delayed motor skills. Although the severity of the disorder varies, many patients are nonverbal and have hypotonia with inability to sit or walk. Early-onset epilepsy is common and may be refractory to treatment, leading to epileptic encephalopathy and further interruption of developmental progress. Most patients have feeding difficulties with poor overall growth and dysmorphic facial features, as well as significant dental anomalies resembling amelogenesis imperfecta. The phenotype is reminiscent of Kohlschutter-Tonz syndrome (KTZS; 226750). More variable features of DHDBV include visual defects, behavioral abnormalities, and nonspecific involvement of other organ systems (summary by den Hoed et al., 2021).

Professional guidelines

PubMed

Zuberi SM, Wirrell E, Yozawitz E, Wilmshurst JM, Specchio N, Riney K, Pressler R, Auvin S, Samia P, Hirsch E, Galicchio S, Triki C, Snead OC, Wiebe S, Cross JH, Tinuper P, Scheffer IE, Perucca E, Moshé SL, Nabbout R
Epilepsia 2022 Jun;63(6):1349-1397. Epub 2022 May 3 doi: 10.1111/epi.17239. PMID: 35503712
Migdady I, Rosenthal ES, Cock HR
Anaesthesia 2022 Jan;77 Suppl 1:78-91. doi: 10.1111/anae.15606. PMID: 35001380
Abboud H, Probasco JC, Irani S, Ances B, Benavides DR, Bradshaw M, Christo PP, Dale RC, Fernandez-Fournier M, Flanagan EP, Gadoth A, George P, Grebenciucova E, Jammoul A, Lee ST, Li Y, Matiello M, Morse AM, Rae-Grant A, Rojas G, Rossman I, Schmitt S, Venkatesan A, Vernino S, Pittock SJ, Titulaer MJ; Autoimmune Encephalitis Alliance Clinicians Network
J Neurol Neurosurg Psychiatry 2021 Jul;92(7):757-768. Epub 2021 Mar 1 doi: 10.1136/jnnp-2020-325300. PMID: 33649022Free PMC Article

Recent clinical studies

Etiology

Muro VL, Yip S, Huh L, Connolly MB
J Clin Neurophysiol 2013 Aug;30(4):344-7. doi: 10.1097/WNP.0b013e31829de004. PMID: 23912571
Nixon Speechley K, Levin SD, Wiebe S, Blume WT
Epilepsia 1999 Feb;40(2):225-31. doi: 10.1111/j.1528-1157.1999.tb02079.x. PMID: 9952271

Diagnosis

Yamamoto M, Manabe T, Yokokawa K, Tsuzaka K, Yamada M, Miyanaga R, Saito T, Yamamoto D, Matsumura A, Suzuki S, Hisahara S
Intern Med 2023 Jun 15;62(12):1827-1833. Epub 2022 Nov 2 doi: 10.2169/internalmedicine.0356-22. PMID: 36328574Free PMC Article
Lee WK, Kim H, Bae MI, Choi SH, Min KT
Korean J Anesthesiol 2018 Dec;71(6):483-485. Epub 2018 May 9 doi: 10.4097/kja.d.17.00069. PMID: 29739181Free PMC Article
Nakakura H, Ashida A, Matsumura H, Murata T, Nagatoya K, Shibahara N, Inoue T, Tamai H
Ther Apher Dial 2009 Feb;13(1):71-6. doi: 10.1111/j.1744-9987.2009.00607.x. PMID: 19379173
Matsumura K, Nakasu S, Tanaka T, Nioka H, Matsuda M
Neurol Med Chir (Tokyo) 2005 Jan;45(1):59-65. doi: 10.2176/nmc.45.59. PMID: 15699624
Nixon Speechley K, Levin SD, Wiebe S, Blume WT
Epilepsia 1999 Feb;40(2):225-31. doi: 10.1111/j.1528-1157.1999.tb02079.x. PMID: 9952271

Therapy

Lee WK, Kim H, Bae MI, Choi SH, Min KT
Korean J Anesthesiol 2018 Dec;71(6):483-485. Epub 2018 May 9 doi: 10.4097/kja.d.17.00069. PMID: 29739181Free PMC Article
Muro VL, Yip S, Huh L, Connolly MB
J Clin Neurophysiol 2013 Aug;30(4):344-7. doi: 10.1097/WNP.0b013e31829de004. PMID: 23912571
Nakakura H, Ashida A, Matsumura H, Murata T, Nagatoya K, Shibahara N, Inoue T, Tamai H
Ther Apher Dial 2009 Feb;13(1):71-6. doi: 10.1111/j.1744-9987.2009.00607.x. PMID: 19379173
Engebretsen KM, Harris CR, Wood JE
J Emerg Med 2003 Aug;25(2):163-6. doi: 10.1016/s0736-4679(03)00164-1. PMID: 12902002

Prognosis

Muro VL, Yip S, Huh L, Connolly MB
J Clin Neurophysiol 2013 Aug;30(4):344-7. doi: 10.1097/WNP.0b013e31829de004. PMID: 23912571
Nakakura H, Ashida A, Matsumura H, Murata T, Nagatoya K, Shibahara N, Inoue T, Tamai H
Ther Apher Dial 2009 Feb;13(1):71-6. doi: 10.1111/j.1744-9987.2009.00607.x. PMID: 19379173
Nixon Speechley K, Levin SD, Wiebe S, Blume WT
Epilepsia 1999 Feb;40(2):225-31. doi: 10.1111/j.1528-1157.1999.tb02079.x. PMID: 9952271

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...